Rosiglitazone Impurity 1 | CAS 768-38-7 - Request Quote
Rosiglitazone Impurity 1
| SZ CAT No: | SZ-R075002 |
| CAS No | 768-38-7 |
| Mol.F. | C8H12O2 |
| Mol.Wt. | 140.2 |
| Inv. Status | Synthesis on demand |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Rosiglitazone Impurity 1 is chemically 3,4-Dimethylcyclopent-3-ene-1-carboxylic acid. Rosiglitazone Impurity 1 is supplied with detailed characterization data compliant with regulatory guideline. Rosiglitazone Impurity 1 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Rosiglitazone.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 768-38-7
Purchase 768-38-7
Order 768-38-7
Enquire 768-38-7
price of 768-38-7
768-38-7 Supplier
768-38-7 Manufacturer
768-38-7 Exporter
buy high quality Rosiglitazone Impurity 1
Purchase Rosiglitazone Impurity 1
Rosiglitazone Impurity 1 suppliers
Rosiglitazone Impurity 1 manufacturers
Rosiglitazone Impurity 1 price
Order Rosiglitazone Impurity 1
Enquire Rosiglitazone Impurity 1
Rosiglitazone Impurity 1 cost
Rosiglitazone Impurity 1 Supplier
Rosiglitazone Impurity 1 Distributor
Rosiglitazone Impurity 1 for Method Validation
Rosiglitazone Reference Standard
Rosiglitazone Impurity 1 for ANDA Filing
Rosiglitazone Impurity 1 for Forced Degradation Studies
Rosiglitazone Impurity 1 Identification Standards
Rosiglitazone Impurity 1 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.


